Gene name: YHL042W
Organism: Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Subcellular localization: Predicted to localize to the endoplasmic reticulum (ER) and vacuole, with experimental validation showing partial co-localization with ER markers and cytosolic presence .
YHL042W Antibody follows the canonical immunoglobulin structure:
Heavy and light chains: Two identical heavy chains (50–70 kDa each) and two light chains (25 kDa each) .
Functional regions:
A protein-protein interaction-based method predicted YHL042W’s localization, which was experimentally validated using GFP fusion and live-cell imaging :
| Parameter | Prediction | Experimental Observation |
|---|---|---|
| Primary Localization | ER | Partial ER co-localization |
| Secondary Sites | Vacuole | Cytosolic signal observed |
| Mutant Phenotype | ER morphology defects | Disrupted perinuclear ER in Δyhl042w |
This study confirmed YHL042W’s role in ER structure maintenance .
Functional Analysis: Investigate YHL042W’s role in ER-vacuole trafficking and stress response pathways.
Interactome Mapping: Identify binding partners using immunoprecipitation-mass spectrometry .
Structural Studies: Resolve the YHL042W-Antibody complex via cryo-EM to guide therapeutic engineering .
YHL042W is a gene that encodes a protein in Saccharomyces cerevisiae, commonly known as Baker's yeast. Specifically, it is found in strain ATCC 204508 / S288c, which is a reference strain widely used in yeast genetics research. The protein encoded by YHL042W has a UniProt accession number of P38729 . Understanding the organism and strain specificity is critical for researchers designing experiments, as antibody reactivity may vary significantly between different yeast strains or related fungal species. When planning experiments, researchers should account for potential evolutionary divergence in the protein sequence if working with non-S288c strains.
Based on validated characterization data, the YHL042W antibody is suitable for specific research applications including ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) . These applications have been verified through standard antibody validation protocols. For Western blot applications, researchers should consider that the antibody has been purified using Protein A/G methodology, which maintains the structural integrity of the IgG molecules. When using this antibody for experimental applications, it's important to follow established protocols that have demonstrated successful detection of the target protein.
Proper validation of YHL042W antibody specificity should follow similar approaches to those used by YCharOS for other antibodies. This includes testing the antibody against wild-type cell lysates alongside knockout cell lysates or genetic deletion strains . A specific and selective antibody will show bands only in the wild-type lane when performing Western blot analysis. Multiple bands in wild-type samples could represent splice isoforms, multimers, or post-translationally modified forms of the protein. When validating for immunoprecipitation or immunofluorescence applications, similar knockout control experiments should be performed. Additionally, researchers could consider using recombinant YHL042W protein as a positive control, which is available with some commercial antibody preparations .
The YHL042W antibody should be stored at -20°C or -80°C for long-term stability and maintained activity . Antibody aliquoting is recommended to avoid repeated freeze-thaw cycles, which can lead to protein denaturation and reduced activity. When working with the antibody, it should be thawed on ice and kept cold during experimental procedures. For shipping purposes, the antibody requires blue ice conditions to maintain its integrity during transport . Short-term storage (1-2 weeks) at 4°C is possible but not recommended for extended periods as it may lead to reduced antibody performance over time.
When working with YHL042W antibody, several controls should be included to ensure experimental validity. These include:
Positive control: Using the recombinant immunogen protein/peptide provided with some commercial antibody packages .
Negative control: Including pre-immune serum in parallel experiments to identify potential non-specific binding .
Genetic control: Utilizing YHL042W deletion strains (when available) to confirm antibody specificity.
Loading control: Including antibodies against housekeeping proteins such as actin or GAPDH in Western blot experiments.
Secondary antibody control: Running a lane with secondary antibody only to identify potential non-specific binding from the secondary antibody.
Including these controls helps validate experimental findings and address potential concerns during peer review of research manuscripts.
For optimal Western blot analysis using YHL042W antibody, researchers should consider the following methodological approach based on protocols used for similar yeast protein antibodies:
Sample preparation: Extract proteins using a buffer containing 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% NP-40, and protease inhibitors. Approximately 50 μg of total protein should be loaded per well .
Gel electrophoresis: Use a 10% SDS-PAGE gel for optimal separation of YHL042W protein .
Transfer: Transfer to PVDF membrane using standard wet or semi-dry transfer methods.
Blocking: Block with 5% non-fat dry milk in TBST (Tris-buffered saline with 0.1% Tween-20) for 1 hour at room temperature.
Primary antibody incubation: Dilute the YHL042W antibody at 1:1,000 to 1:10,000 (optimal dilution should be determined empirically) .
Secondary antibody: Use HRP-conjugated goat anti-rabbit secondary antibody at 1:10,000 dilution .
Detection: Visualize using enhanced chemiluminescence (ECL) reagents.
Optimization of these conditions for each specific experimental setup is recommended, as factors such as protein abundance and sample complexity can affect results.
Cross-reactivity issues with YHL042W antibody can be addressed through several methodological approaches:
Epitope mapping: Identify the specific epitope(s) recognized by the antibody to predict potential cross-reactive proteins.
Pre-absorption: Incubate the antibody with excess recombinant YHL042W protein before use to reduce non-specific binding.
Sequential immunoprecipitation: Perform multiple rounds of immunoprecipitation to deplete cross-reactive proteins.
Western blot validation: Compare banding patterns between wild-type and YHL042W deletion strains.
Mass spectrometry validation: Confirm the identity of immunoprecipitated proteins through mass spectrometry analysis.
When investigating potential cross-reactivity with related proteins, researchers should consider that polyclonal antibodies like the YHL042W antibody recognize multiple epitopes on the target protein, which can increase the likelihood of cross-reactivity but also improve detection sensitivity .
For co-immunoprecipitation studies using YHL042W antibody, the following methodological approach is recommended:
Lysate preparation: Prepare yeast cell lysates in a buffer containing 50mM HEPES pH 7.5, 150mM NaCl, 0.1% NP-40, 10% glycerol, 1mM EDTA, and protease inhibitors.
Pre-clearing: Pre-clear lysates with Protein A/G beads to reduce non-specific binding.
Antibody binding: Incubate pre-cleared lysates with YHL042W antibody (2-5 μg per mg of total protein) overnight at 4°C.
Immunoprecipitation: Add Protein A/G beads and incubate for 2-4 hours at 4°C.
Washing: Wash beads 4-5 times with lysis buffer to remove non-specifically bound proteins.
Elution: Elute bound proteins by boiling in SDS sample buffer.
Analysis: Analyze co-immunoprecipitated proteins by Western blot or mass spectrometry.
This approach allows researchers to identify protein-protein interactions involving YHL042W, which can provide insights into its functional role in yeast cellular processes.
For protein localization studies using immunofluorescence microscopy with YHL042W antibody, researchers should follow this methodological workflow:
Sample preparation: Fix yeast cells with 4% formaldehyde for 30 minutes, followed by cell wall digestion with zymolyase.
Permeabilization: Permeabilize cells with 0.1% Triton X-100 for 10 minutes.
Blocking: Block with 3% BSA in PBS for 1 hour at room temperature.
Primary antibody: Incubate with YHL042W antibody at an empirically determined dilution (typically 1:100 to 1:500) overnight at 4°C.
Secondary antibody: Incubate with fluorophore-conjugated anti-rabbit secondary antibody (1:500) for 1 hour at room temperature.
Counterstaining: Counterstain with DAPI to visualize nuclei.
Controls: Include YHL042W deletion strains as negative controls.
Imaging: Capture images using confocal microscopy for optimal resolution.
This approach allows researchers to determine the subcellular localization of YHL042W protein under various experimental conditions or in different genetic backgrounds.
Optimizing antibody dilutions for YHL042W antibody across different applications requires systematic titration approaches:
Western blot optimization:
Start with a broad range of dilutions (1:500, 1:1,000, 1:5,000, 1:10,000).
Evaluate signal-to-noise ratio at each dilution.
Select the dilution that provides clear specific bands with minimal background.
ELISA optimization:
Perform a checkerboard titration with antigen concentrations ranging from 0.1-10 μg/mL and antibody dilutions from 1:100 to 1:10,000.
Calculate signal-to-background ratios for each combination.
Plot titration curves to identify the optimal working range.
Immunofluorescence optimization:
Test dilutions ranging from 1:50 to 1:500.
Assess signal intensity and specificity at each dilution.
Include knockout controls to confirm specificity.
Optimization should be performed for each new lot of antibody and for each specific experimental setup, as factors such as sample type and preparation method can influence optimal dilution.
For accurate quantification of YHL042W protein levels, researchers should consider the following methodological approaches:
Western blot quantification:
ELISA quantification:
Develop a sandwich ELISA using capture and detection antibodies.
Generate standard curves with purified recombinant protein.
Ensure samples fall within the linear range of the standard curve.
Calculate protein concentrations using regression analysis.
Flow cytometry quantification:
Use antibody-based flow cytometry to measure cellular YHL042W levels.
Include calibration beads to convert fluorescence intensity to molecules of equivalent soluble fluorochrome (MESF).
Compare results across different yeast strains or conditions.
These quantitative approaches enable researchers to detect subtle changes in YHL042W protein expression under different experimental conditions.
For multiplex analysis combining YHL042W antibody with other antibodies, researchers should consider these methodological approaches:
Western blot multiplexing:
Use primary antibodies from different host species (e.g., rabbit anti-YHL042W with mouse anti-tag antibodies).
Employ fluorescent secondary antibodies with different emission spectra.
Strip and reprobe membranes sequentially if using antibodies from the same species.
Immunofluorescence multiplexing:
Combine YHL042W antibody with antibodies against other markers from different host species.
Use secondary antibodies with distinct fluorophores that have minimal spectral overlap.
Include appropriate controls to confirm specificity of each antibody.
Multiplex immunoprecipitation:
Perform sequential immunoprecipitations to study protein complexes.
Use antibody conjugated directly to beads to avoid interference from detecting antibodies.
Validate multiplex results using single-antibody approaches.
These multiplex approaches enable researchers to study protein-protein interactions and co-localization involving YHL042W.
When using YHL042W antibody across different yeast genetic backgrounds, researchers should consider:
Sequence conservation:
Check the YHL042W sequence conservation across different Saccharomyces strains.
Predict potential epitope differences that might affect antibody binding.
Validate antibody reactivity in each strain before conducting extensive experiments.
Expression levels:
Different genetic backgrounds may have varying YHL042W expression levels.
Adjust loading amounts or antibody concentrations accordingly.
Include loading controls appropriate for each genetic background.
Post-translational modifications:
Different yeast strains may process the YHL042W protein differently.
Be aware that post-translational modifications might affect antibody binding.
Look for potential mobility shifts in Western blots when comparing strains.
Cross-validation:
Confirm results using complementary techniques such as RNA analysis or tagged versions of the protein.
Consider generating strain-specific standard curves for quantification.
These considerations help ensure reliable and reproducible results when studying YHL042W across different yeast genetic backgrounds.
Interpreting complex banding patterns in Western blots using YHL042W antibody requires systematic analysis:
Expected molecular weight analysis:
Band pattern analysis table:
| Band Size (kDa) | Potential Identity | Validation Approach |
|---|---|---|
| Predicted MW | Full-length YHL042W | Absent in knockout strains |
| Higher MW bands | Post-translationally modified forms | Treatment with phosphatase or glycosidase |
| Lower MW bands | Degradation products or fragments | Protease inhibitor treatment during extraction |
| Unexpected bands | Cross-reactive proteins | Peptide competition assay |
Pattern comparison:
Compare banding patterns across different experimental conditions.
Determine which bands change in response to experimental manipulations.
Focus analysis on consistently observed bands across replicates.
This systematic approach helps researchers distinguish specific signal from background and interpret complex Western blot results accurately.
When troubleshooting weak or absent signals using YHL042W antibody, researchers should consider this methodological flowchart:
Sample preparation issues:
Ensure protein extraction is performed under conditions that preserve YHL042W integrity.
Check total protein concentration using Bradford or BCA assays.
Verify extraction efficiency using known abundant proteins.
Antibody-related factors:
Confirm antibody stability and storage conditions.
Test a new antibody aliquot to rule out degradation.
Optimize antibody concentration through titration experiments.
Protocol optimization:
Increase protein loading amount.
Extend primary antibody incubation time (overnight at 4°C).
Try different blocking reagents (BSA vs. milk).
Use enhanced sensitivity detection systems.
Biological factors:
Verify if YHL042W is expressed under your experimental conditions.
Consider induction protocols if expression is low.
Use positive control samples known to express the protein.
Systematic application of these troubleshooting approaches can help researchers overcome detection challenges with YHL042W antibody.
Validating findings from YHL042W antibody experiments requires multiple complementary approaches:
Genetic validation:
Use YHL042W deletion strains as negative controls.
Perform genetic complementation with tagged versions of YHL042W.
Apply CRISPR/Cas9 editing to modify the endogenous gene.
Transcript-level validation:
Conduct RT-qPCR to measure YHL042W mRNA levels.
Perform RNA-seq to analyze expression patterns.
Use Northern blotting for transcript size verification.
Protein-level validation:
Express epitope-tagged versions of YHL042W.
Detect the protein using tag-specific antibodies.
Apply mass spectrometry to confirm protein identity.
Functional validation:
Assess phenotypic changes in YHL042W mutants.
Perform rescue experiments with wild-type protein.
Conduct domain-specific mutational analysis.
Integrating these complementary approaches provides robust validation of findings and addresses potential antibody specificity concerns.
For using YHL042W antibody in chromatin immunoprecipitation experiments, researchers should follow this methodological workflow:
Sample preparation:
Cross-link yeast cells with 1% formaldehyde for 15-20 minutes.
Harvest cells and lyse using glass bead disruption.
Sonicate chromatin to generate 200-500 bp fragments.
Immunoprecipitation:
Pre-clear chromatin with Protein A/G beads.
Incubate cleared chromatin with YHL042W antibody (2-5 μg per ChIP reaction).
Collect immunoprecipitated complexes using Protein A/G beads.
Wash stringently to remove non-specific interactions.
DNA recovery and analysis:
Reverse cross-links and purify DNA.
Analyze by qPCR targeting potential binding sites.
Alternatively, perform ChIP-seq for genome-wide binding profile.
Controls:
Include IgG control immunoprecipitation.
Use YHL042W deletion strain as negative control.
Include positive control regions based on literature or predictions.
This approach enables researchers to investigate potential chromatin association or DNA-binding properties of YHL042W protein.
When developing ELISAs using YHL042W antibody, researchers should consider these methodological aspects:
ELISA format selection:
Direct ELISA: Coat plate with yeast lysate containing YHL042W.
Indirect ELISA: Coat with purified YHL042W protein.
Sandwich ELISA: Use capture and detection antibodies (requires two different antibodies).
Protocol optimization:
Coating concentration: Titrate antigen from 0.1-10 μg/mL.
Blocking: Test different blockers (BSA, milk, commercial blockers).
Antibody dilution: Optimize primary antibody concentration (start with 1:100-1:5,000).
Detection system: Choose appropriate enzyme conjugate and substrate.
Standardization:
Create standard curves with recombinant YHL042W protein.
Include positive and negative controls in each plate.
Determine assay dynamic range, sensitivity, and reproducibility.
Sample preparation:
Optimize lysis conditions to preserve YHL042W epitopes.
Consider sample dilution series to ensure measurements fall within linear range.
Following these considerations helps researchers develop robust ELISA protocols for YHL042W detection and quantification.
Studying post-translational modifications (PTMs) of YHL042W using antibody-based approaches requires these methodological strategies:
PTM detection workflow:
Immunoprecipitate YHL042W protein using the antibody.
Analyze immunoprecipitated material by Western blot.
Probe with PTM-specific antibodies (phospho, ubiquitin, SUMO, etc.).
Alternatively, analyze by mass spectrometry for comprehensive PTM mapping.
PTM-specific treatments:
Treat samples with phosphatase to remove phosphorylation.
Use deubiquitinating enzymes to remove ubiquitin modifications.
Apply glycosidases to cleave glycosyl groups.
Compare migration patterns before and after treatments.
Modification-inducing conditions:
Subject yeast cells to stress conditions known to induce specific PTMs.
Compare YHL042W modifications across different growth phases.
Analyze effects of signaling pathway activators or inhibitors.
Genetic approaches:
Examine YHL042W in yeast strains with mutations in PTM machinery.
Create YHL042W mutants lacking potential modification sites.
These approaches enable researchers to identify and characterize post-translational modifications that may regulate YHL042W function.
Current limitations and future directions in YHL042W antibody research include:
Current limitations:
Limited availability of monoclonal antibodies against YHL042W.
Insufficient validation across diverse yeast strains and species.
Incomplete characterization for all potential applications.
Lack of epitope mapping for many commercial antibodies.
Potential future developments:
Development of application-specific monoclonal antibodies.
Generation of modification-specific antibodies (phospho-YHL042W, etc.).
Creation of yeast-optimized nanobodies for live-cell imaging.
Integration with emerging protein detection technologies.
Emerging methodologies:
Proximity labeling approaches (BioID, APEX) using YHL042W as bait.
Single-molecule detection methods for low-abundance analysis.
Spatial proteomics approaches to map YHL042W subcellular localization.
These developments would address current limitations and expand the research toolkit for studying YHL042W function and regulation in yeast biology.
Research using YHL042W antibody connects to broader yeast biology questions through several avenues:
Functional genomics implications:
YHL042W is part of the systematic genome-wide studies in yeast.
Antibody-based studies help validate computational predictions of function.
Protein-level analysis complements genetic and transcriptomic approaches.
Evolutionary biology perspectives:
Studying YHL042W across yeast species can reveal evolutionary conservation patterns.
Cross-species reactivity of the antibody provides insights into protein structure conservation.
Functional divergence can be assessed at the protein level.
Systems biology integration:
YHL042W antibody-based studies contribute to protein interaction networks.
Quantitative analysis helps build dynamic models of yeast cellular processes.
Multi-omics integration includes antibody-derived proteomic data.
Translational relevance:
Fundamental studies in yeast often translate to higher eukaryotes.
Methodologies developed for YHL042W antibody applications can be adapted for other systems.